NDA 19708, held by B Braun. Potassium Chloride; Sodium Chloride.
As of Nov 13, 2026, NDA 19708 (Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride 0.075% In Sodium Chloride 0.9% In Plastic Container, Potassium Chloride 0.11% In Sodium Chloride 0.9% In Plastic Container), held by B Braun, was first approved by FDA on Sep 29, 1989, with 14 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Potassium Chloride in 0.9% Sodium Chloride Injection is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 29, 1989 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Potassium Chloride 0.037% In Sodium Chloride 0.9% In Plastic Container37MG/100ML;900MG/100ML · injectable;injection | Potassium Chloride; Sodium Chloride | Discontinued |
| Potassium Chloride 0.075% In Sodium Chloride 0.9% In Plastic Container75MG/100ML;900MG/100ML · injectable;injection | Potassium Chloride; Sodium Chloride | Discontinued |
| Potassium Chloride 0.11% In Sodium Chloride 0.9% In Plastic Container110MG/100ML;900MG/100ML · injectable;injection | Potassium Chloride; Sodium Chloride | Discontinued |
| Potassium Chloride 0.15% In Sodium Chloride 0.9% In Plastic Container150MG/100ML;900MG/100ML · injectable;injection | Potassium Chloride; Sodium Chloride | Rx |
| Potassium Chloride 0.22% In Sodium Chloride 0.9% In Plastic Container220MG/100ML;900MG/100ML · injectable;injection | Potassium Chloride; Sodium Chloride | Discontinued |
| Potassium Chloride 0.3% In Sodium Chloride 0.9% In Plastic Container300MG/100ML;900MG/100ML · injectable;injection | Potassium Chloride; Sodium Chloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 17, 2026 | Supplement 40Labeling · Standard review | Approved | |
| Aug 22, 2014 | Supplement 22Manufacturing · Standard review | Approved | None posted |
| Aug 31, 2005 | Supplement 16Labeling · Standard review | Approved | |
| Sep 27, 2004 | Supplement 13Labeling · Standard review | Approved | |
| Jul 23, 2002 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Mar 8, 2002 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Mar 12, 2001 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| May 4, 1999 | Supplement 8Manufacturing · Standard review | Approved | None posted |
| Sep 25, 1998 | Supplement 7Manufacturing · Standard review | Approved | None posted |
| Jul 21, 1993 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Dec 29, 1992 | Supplement 5Manufacturing · Standard review | Approved | None posted |
| Aug 29, 1991 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Sep 21, 1990 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Sep 18, 1990 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Sep 29, 1989 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters